Results 21 to 30 of about 5,662 (132)

Crimean-Congo hemorrhagic fever with hepatic impairment and vaginal hemorrhage: a case report

open access: yesJournal of Medical Case Reports, 2018
Background Crimean-Congo hemorrhagic fever is a tick-borne disease described in more than 30 countries in Europe, Asia, and Africa. Albania is located in the southwestern part of the Balkan Peninsula.
Ermira Muco   +8 more
doaj   +1 more source

Fatal Case of Crimean-Congo Hemorrhagic Fever, Portugal, 2024

open access: yesEmerging Infectious Diseases
We report a fatal case of Crimean-Congo hemorrhagic fever in Portugal. An 83-year-old man, initially suspected of having Mediterranean spotted fever, was later confirmed to have Crimean-Congo hemorrhagic fever by the detection of viral genome in the ...
Líbia Zé-Zé   +10 more
doaj   +1 more source

Crimean-Congo hemorrhagic fever infections reported by ProMED

open access: yesInternational Journal of Infectious Diseases, 2014
Objective: There are limited sources describing the global burden of emerging diseases. We reviewed the Crimean-Congo hemorrhagic fever virus (CCHFV) infections reported by ProMED and assessed the reliability of the data retrieved compared to published ...
Yavuz Ince   +6 more
doaj   +1 more source

Cellular immune response of Amblyomma sculptum and Amblyomma americanum to entomopathogenic fungi: Implications for biological tick control

open access: yesMedical and Veterinary Entomology, EarlyView.
Amblyomma sculptum showed a plasmatocyte‐dominant haemocyte profile. Beauveria bassiana increased plasmatocytes and reduced granulocytes, whereas Metarhizium robertsii did not cause significant changes. Amblyomma americanum showed a granulocyte‐dominant haemocyte profile. Beauveria bassiana reduced total haemocytes and granulocytes. B.
Cárita de Souza Ribeiro‐Silva   +7 more
wiley   +1 more source

Geographical distribution of Hyalomma marginatum Koch, 1844 in northwestern Spain from 2019 to 2024: A one health approach

open access: yesMedical and Veterinary Entomology, EarlyView.
This study confirms the presence of the tick Hyalomma marginatum Koch, 1844, a known vector of the Crimean‐Congo hemorrhagic fever virus at Galicia. Most ticks were encountered on humans and livestock, with numbers rising between 2019 and 2024, especially during spring and in warm‐summer Mediterranean southwest areas of the studied region.
Inês Abreu Ramos   +10 more
wiley   +1 more source

An international study on emerging arboviral infections and blood safety

open access: yesTransfusion, EarlyView.
Abstract Background Emerging and re‐emerging arboviral infections are a risk to blood safety. We conducted an international survey on how blood establishments respond to current and future arbovirus threats. Study Design and Methods A questionnaire on arbovirus donor deferral strategies, pathogen reduction, and donation screening was distributed to ...
Piya Rajendra   +40 more
wiley   +1 more source

Crimean‐Congo Haemorrhagic Fever Virus Exposure in Horses and Donkeys in Border Livestock Markets of Nigeria

open access: yesZoonoses and Public Health, EarlyView.
ABSTRACT Introduction Crimean‐Congo haemorrhagic fever virus (CCHFV) is a tick‐borne zoonotic pathogen of major public health importance in Africa. Although CCHFV exposure has been reported in several livestock species in Nigeria, data on equids remain limited despite their extensive involvement in livestock movement and trade.
David O. Ehizibolo   +14 more
wiley   +1 more source

Crimean-Congo hemorrhagic fever with severe bradycardia treated with Theophylline [PDF]

open access: yesRevista da Sociedade Brasileira de Medicina Tropical
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral hemorrhagic fever caused by Nairovirus and characterized by fever, myalgia, arthralgia, and hemorrhagic manifestations. Severe bradycardia is a rare complication of the disease. We present a 30-
Murat Aydın, Nurten Nur Aydın
doaj   +1 more source

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1650-1661, June 2026.
AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland   +48 more
wiley   +1 more source

Crimean-Congo Hemorrhagic Fever, Mauritania

open access: yesEmerging Infectious Diseases, 2004
From February to August 2003, 38 persons were infected with Crimean-Congo hemorrhagic fever (CCHF) virus in Mauritania; 35 of these persons were residents of Nouakchott.
Pierre Nabeth   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy